CALIBRA
Latest round
- Series C
Last raised
- May 2022
Total raised
- $62M
Investors
- 9
About CALIBRA
Established in 2016 and based in Hangzhou, China, CALIBRA is a high-tech company that engages in researching and developing, clinical transformation and application of a new generation of biomarker material spectrum detection technology. Liu Huafen, the CEO of the company, was the global director of SCIEXLabs, the application innovation platform of the Danaher Group SCIEX. The company has more than ten ultra-high resolution and quantitative mass spectrometers for the analysis of complex matrix samples, as well as Hamilton Microlab STAR M high-throughput automated pipetting workstations and other pre-processing systems. The services provided by the company include clinical research and health management, metabolomics, Pharma CRO and environmental/toxicology. The products provided by the company include vitamin series, bile acid series, drug concentration series and other supporting reagents; chromatographic columns, pre-treatment plates, 96 microplates, 96SLE plates and other experimental consumables. The company will focus on the research and development and registration of innovative instruments and reagents, and will accelerate the layout of our national marketing network and the expansion of our product capacity.
Who invested in CALIBRA
9 investors across 3 rounds
See all investors in CALIBRA
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CALIBRA
Who invested in CALIBRA?
CALIBRA has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CALIBRA raised?
CALIBRA has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did CALIBRA last raise money?
CALIBRA's most recent round on record is a Series C, in May 2022.
What does CALIBRA do?
Established in 2016 and based in Hangzhou, China, CALIBRA is a high-tech company that engages in researching and developing, clinical transformation and application of a new generation of biomarker material spectrum detection technology.
Where is CALIBRA headquartered?
CALIBRA is headquartered in Hangzhou, China.
Which VCs invest in companies like CALIBRA?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Taibao Capital and Hengxu Capital back healthcare companies at CALIBRA's stage. Their profiles are linked below.
VCs backing healthcare startups at Series C
Raising like CALIBRA? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.